II/III型胸腹主动脉瘤开放、杂交与开窗分支腔内修复的结局比较
开放手术任何脊髓缺血风险低于FEVAR,但永久性脊髓缺血三组无差异。
要点
- 调整后开放手术30天死亡风险是FEVAR的3.6倍(95%CI 1.4-9.2)。
- 永久性脊髓缺血三组无差异,开放手术任何脊髓缺血风险低于FEVAR。
- 开放手术术后1-6个月生存劣势显著,但1年和5年生存无差异。
核心结论
- II/III型胸腹主动脉瘤修复无论采用何种策略均有显著并发症风险。
- 调整术前危险因素后,FEVAR的30天死亡风险最低,支持在解剖适合的择期患者中作为一线治疗。
研究设计与样本
- 采用逆概率加权倾向分析进行组间比较,Cox回归估计生存,累积发生率评估再手术风险。
临床怎么用
- 在解剖适合的择期II/III型胸腹主动脉瘤患者中,可优先考虑FEVAR以降低30天死亡风险。
- 开放手术术后早期(1-6个月)生存劣势需关注,但长期生存与FEVAR/杂交相当。
局限性
- 单中心回顾性设计,样本量有限,存在选择偏倚可能。
- 杂交组样本量较小(40例),可能影响组间比较效能。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Open repair of extent II and III thoracoabdominal aortic aneurysms (TAAA) is associated with substantial morbidity. Alternative strategies, such as hybrid operations combining proximal thoracic endovascular aortic repair with either staged open distal TAAA repair or visceral debranching (hybrid), as well as fenestrated/branched endografts (FEVAR), have been increasingly reported; however, benefits of these approaches compared with direct open surgery remain unclear. The purpose of this study was to compare outcomes of these three different strategies in the management of extent II/III TAAA. METHODS: All extent II/III TAAA repairs (2002-2018) for nonmycotic, degenerative aneurysm or chronic dissection at a single institution were reviewed. The primary end point was 30-day mortality. Secondary end points included incidence of spinal cord ischemia (SCI), complications, unplanned re-operation, 90-day readmission, and out-of-hospital survival. To mitigate impact of covariate imbalance and selection bias, intergroup comparisons were made using inverse probability weighted-propensity analysis. Cox regression was used to estimate survival while cumulative incidence was used to determine reoperation risk. RESULTS: One hundred ninety-eight patients (FEVAR, 92; hybrid, 40; open, 66) underwent repair. In unadjusted analysis, compared with hybrid/open patients, FEVAR patients were significantly older with more cardiovascular risk factors, but less likely to have a connective tissue disorder or dissection-related indication. Unadjusted 30-day mortality and complication rates were: 30-day mortality, FEVAR 4%, hybrid 13%, open 12% (P = .01); and complications, FEVAR 36%, hybrid 33%, open 50% (P = .11). Permanent SCI was not different among groups (FEVAR 3%, hybrid 3%, open 6%; P = .64). In adjusted analysis, 30-day mortality risk was greater for open vs FEVAR (hazard ratio, 3.6; 95% confidence interval, 1.4-9.2; P = .01) with no difference for hybrid vs open/FEVAR. There was significantly lower risk of any SCI for open vs FEVAR (hazard ratio, 0.3; 95% confidence interval, 0.09-0.96; P = .04); however, no difference in risk of permanent SCI was detected among the three groups. There was no difference in complications or unplanned reoperation, but open patients had the greatest risk of unplanned 90-day readmission. There was a time-varying effect on survival probability, with open repair having a significant survival disadvantage in the first 1 to 6 months after the procedure compared with hybrid/FEVAR patients (Cox model P = .03), but no difference in survival at 1 and 5 years (1- and 5-year survival: FEVAR, 86 ± 3%, 55 ± 8%; hybrid, 86 ± 5%, 60 ± 11%; open 69 ± 7%, 59 ± 8%; Cox-model P = .10). CONCLUSIONS: Extent II/III TAAA repair, regardless of operative strategy, is associated with significant morbidity risk. FEVAR is associated with the lowest 30-day mortality risk compared with hybrid and open repair when estimates are adjusted for preoperative risk factors. These data support greater adoption of FEVAR as first-line therapy to treat complex TAAA disease in anatomically suitable patients who present electively.
引用
- Arnaoutakis DJ, Scali ST, Beck AW, et al. Comparative outcomes of open, hybrid, and fenestrated branched endovascular repair of extent II and III thoracoabdominal aortic aneurysms. J Vasc Surg. 2019. PMID: 31727462. doi:10.1016/j.jvs.2019.08.236
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。